OKAYAMA UNIVERSITY IMAGE: SCIENTISTS REPORT THAT METFORMIN, USED TO TREAT TYPE 2 DIABETES MELLITUS, INDUCES ACTIVATION AND PROLIFERATION OF TUMOR-TARGETING CD8+ T-LYMPHOCYTES (CD8TIL), VIA MECHANISMS THAT INVOLVE THE GENERATION OF REACTIVE OXYGEN SPECIES IN MITOCHONDRIA OF CD8TIL AND AN INCREASE IN GLYCOLYSIS. CREDIT: HEIICHIRO UDONO FROM OKAYAMA UNIVERSITY Modern medicine has made slow progress in...
